Menu
GeneBe

2-111150129-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3

The NM_138621.5(BCL2L11):​c.480C>A​(p.Asn160Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

BCL2L11
NM_138621.5 missense

Scores

4
4
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.286
Variant links:
Genes affected
BCL2L11 (HGNC:994): (BCL2 like 11) The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The protein encoded by this gene contains a Bcl-2 homology domain 3 (BH3). It has been shown to interact with other members of the BCL-2 protein family and to act as an apoptotic activator. The expression of this gene can be induced by nerve growth factor (NGF), as well as by the forkhead transcription factor FKHR-L1, which suggests a role of this gene in neuronal and lymphocyte apoptosis. Transgenic studies of the mouse counterpart suggested that this gene functions as an essential initiator of apoptosis in thymocyte-negative selection. Several alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2013]
MIR4435-2HG (HGNC:35163): (MIR4435-2 host gene)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM1
In a mutagenesis_site Retains the ability to induce apoptosis. Abolishes interaction with BCL2; in isoform Bim-alpha3 and isoform BimS. No effect on interaction with BAX. (size 0) in uniprot entity B2L11_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.751

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BCL2L11NM_138621.5 linkuse as main transcriptc.480C>A p.Asn160Lys missense_variant 3/4 ENST00000393256.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BCL2L11ENST00000393256.8 linkuse as main transcriptc.480C>A p.Asn160Lys missense_variant 3/41 NM_138621.5 P1O43521-1
MIR4435-2HGENST00000645030.2 linkuse as main transcriptn.453-113207G>T intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 08, 2024The c.480C>A (p.N160K) alteration is located in exon 3 (coding exon 2) of the BCL2L11 gene. This alteration results from a C to A substitution at nucleotide position 480, causing the asparagine (N) at amino acid position 160 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Benign
-0.027
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
19
DANN
Uncertain
0.99
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.13
N
LIST_S2
Uncertain
0.92
D;D;D;D;D;D;D
M_CAP
Benign
0.026
D
MetaRNN
Pathogenic
0.75
D;D;D;D;D;D;D
MetaSVM
Benign
-0.68
T
MutationTaster
Benign
0.99
N;N;N;N
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-4.1
D;.;.;.;.;D;.
REVEL
Benign
0.20
Sift
Pathogenic
0.0
D;.;.;.;.;D;.
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;.
Polyphen
1.0
D;.;.;.;.;P;.
Vest4
0.92
MutPred
0.81
.;Gain of methylation at N160 (P = 0.0139);.;Gain of methylation at N160 (P = 0.0139);.;Gain of methylation at N160 (P = 0.0139);.;
MVP
0.29
MPC
0.34
ClinPred
0.99
D
GERP RS
-4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.92
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-111907706; API